Last reviewed · How we verify
NCT04135872
Hypoalbuminemia in Mild Acute Stroke and Cognitive Impariment Post-stroke
trial testing strengthened nuitritional treatment in Cognitive Impairment in 435 participants. Completed in 30 August 2018.
30 June 2018
Quick facts
| Lead sponsor | Dongguan People's Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 435 |
| Start date | 1 January 2017 |
| Primary completion | 30 June 2018 |
| Estimated completion | 30 August 2018 |
| Sites | 1 location across China |
Drugs / interventions tested
- strengthened nuitritional treatment
Conditions studied
- Cognitive Impairment — all drugs for Cognitive Impairment →
- Stroke — all drugs for Stroke →
- Albumin; Double — all drugs for Albumin; Double →
Sponsor
Dongguan People's Hospital
Who can join
Adults 40 to 80, any sex, with Cognitive Impairment or Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This registration enrolled patients with acute ischemic stroke within 72 hours after stroke ictus. Patients was identified as first-ever stroke based on past medical histrory. Admission CT was conducted to exclude hemorrhagic stroke, but not those bleeding transformation after ischemia injury. Baseline characteristics, including demographics, vascular risk factors, lab tests and neuroimagings were collected. Patients were followed up for cognitive assessments.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04135872
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cognitive Impairment
Currently open trials in the same condition.
- NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
- NCT07396779 — Cognitive Task-Based Walking Effects on Cognition, Mood, Sleep, and Quality of Life in Older Adults With Brain Fog · NA · active not recruiting
- NCT07084831 — A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment i · Phase 3 · recruiting
- NCT07125378 — Living Independence Through Functional Training · Phase 1, PHASE2 · recruiting
- NCT07268079 — Validation of the VIRADIA App for Neurological and Cognitive Diagnostics in Virtual Reality · recruiting
Other Dongguan People's Hospital trials
Trials by the same sponsor.
- NCT03310931 — Predictive Significance of TEG on END in Patients With Acute Ischemic Stroke · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04135872 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dongguan People's Hospital
- Last refreshed: 24 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04135872.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing